help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 12, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-2368
A more recent version of this article appeared on May 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/5/1751    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Li, Y.
Right arrow Articles by Teng, W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Y.
Right arrow Articles by Teng, W.
Related Collections
Right arrow Autoimmunity
Right arrow Thyroid

Submitted on October 24, 2007
Accepted on February 4, 2008

Anti-thyroperoxidase and anti-thyroglobulin antibodies in a 5-year follow-up survey of populations with different iodine intakes

Yushu Li, Di Teng, Zhongyan Shan, Xiaochun Teng, Haixia Guan, Xiaohui Yu, Chenling Fan, Wei Chong, Fan Yang, Hong Dai, Xiaolan Gu, Yang Yu, Jinyuan Mao, Dong Zhao, Jia Li, Yanyan Chen, Rong Yang, Chenyang Li, and Weiping Teng*

Department of Endocrinology and Metabolism and the Institute of Endocrinology, First Affiliated Hospital, China Medical University, No.155 Nanjing Bei St., Heping District, Shenyang, 110001, China

* To whom correspondence should be addressed. E-mail: Twpendocrine{at}yahoo.com.cn.

Objective: In a follow-up study, we determined the prevalence, incidence, and natural course of positive anti-thyroperoxidase antibodies (TPOAb) and anti-thyroglobulin antibodies (TgAb) in the general population and examined the influences of iodine intake.

Design: The study was conducted in Panshan, Zhangwu and Huanghua, regions with mildly deficient, more than adequate, and excessive iodine intake, respectively. Of the 3,761 unselected subjects who were enrolled at baseline, 3018 participated in the five-year follow-up study. Serum TSH, TPOAb, and TgAb levels were measured.

Results: Among subjects in Panshan, Zhangwu and Huanghua, the prevalence of positive TPOAb was 11.23%, 11.83% and 12.02%, respectively, while 11.23%, 11.17% and 11.26% of subjects were TgAb positive, respectively. In the older population (≥45years), TgAb positive individuals were more frequent in Huanghua than Panshan and Zhangwu (P<0.05). The five-year cumulative incidence of positive TPOAb was 2.08%, 3.84% and 2.84% in Panshan, Zhangwu and Huanghua, respectively, while 2.91%, 3.64% and 5.07% of subjects were TgAb positive, respectively (P<0.05), corresponding to the increase in iodine intake. Subjects who were TPOAb and/or TgAb positive at baseline developed thyroid dysfunctions more frequently than those without antibodies (14.44% vs. 3.31%, P<0.01), there incidence of elevated TSH levels was 1.32%, 8.46%, and 15.38% in Panshan, Zhangwu, and Huanghua, respectively (P<0.05).

Conclusions: Subjects who were TPOAb and TgAb positive at baseline developed thyroid dysfunctions more frequently than seronegative subjects. High iodine intake was a risk factor for developing hypothyroidism in antibody positive subjects. A constant exposure to excessive iodine intake increased the incidence of positive TgAb.


Key words: Anti-thyroperoxidase antibodies • Anti-thyroglobulin antibodies • iodine intake • prevalence • incidence







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society